ABSTRACT
Genome-wide association studies (GWAS) have identified hundreds of genetic variants associated with body weight but the biological relevance of most remains unexplored. Given the critical role of the brain in multiple biological processes associated with body weight regulation, we set out to determine whether genetic variants linked with body mass index (BMI) could be mapped to brain proteins. Using genetic colocalization, we mapped 23 loci from the largest BMI GWAS (n=806,834) to brain proteins (obtained from a dataset of >7000 dorsolateral prefrontal cortex proteins measured by mass spectrometry in >400 individuals). We also performed a proteome-wide Mendelian randomization analysis followed by genetic colocalization, which allowed us to identify an additional 48 brain proteins linked with BMI. Multi-trait colocalization suggested that more than 75% of the protein quantitative trait loci (pQTL)-BMI associations are mediated via protein expression and not via RNA expression. Single-cell sequencing from the human brain cortex revealed that the genes expressing the proteins associated with BMI may be predominantly expressed in oligodendrocytes. In the Québec Family Study, a genetic risk score (GRS) including these brain pQTLs was associated with higher dietary carbohydrate intake and lower lipid intake whereas a GRS including the 67 variants most strongly associated with BMI was not associated with dietary intake. In conclusions, we identified 71 proteins expressed in the prefrontal cortex that may be critical regulators of body weight and possibly dietary intake in humans.
Competing Interest Statement
B.J.A is a consultant for Novartis and Silence Therapeutics and has received research contracts from Pfizer, Ionis Pharmaceuticals and Silence Therapeutics
Funding Statement
EG holds a master's research award from the Fonds de recherche du Quebec: Sante (FRQS). BJA holds a junior scholar award from the FRQS. P.M. is the recipient of the Joseph C. Edwards Foundation granted to Universite Laval. CB is partially supported by the John W. Barton Sr. Chair in Genetics and Nutrition.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The QFS was approved by the Research Ethics Committee of Universite Laval and all participants signed an informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All genome-wide summary statistics used in this study are in the public domain. Data described in the manuscript from the QFS will be made available upon request pending approval from the authors as well as the funding bodies.
